Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Report Date: July 29, 2004
Reporting Period: The filing announces financial results for the three months and 12 months ended May 29, 2004.
Key Financial Metrics
The Form 8-K text serves as a notification of results and incorporates a press release (Exhibit 99.1) by reference. The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release for these figures.
Material Changes
The filing text does not contain specific data regarding material changes versus prior comparable periods. It only confirms the issuance of results for the periods ended May 29, 2004.
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. These details are contained within the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and earnings per share figures for the quarter and year ended May 29, 2004.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Check the press release for any updated financial guidance or strategic outlook provided by management.
- Confirm the status of debt and liquidity positions as detailed in the full financial results.